CLO26-107: A Meta-Analysis and Network Meta-Analysis for Overall Survival of Pembrolizumab Monotherapy Versus Combined With Chemotherapy as First-Line Therapy in No EGFR/ALK-Mutation Advanced or Metastatic Non-Small-Cell Lung Cancer

View at publisher Summarise with VIRAT
Authors: Woojung Yang, Youjin Oh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN